Basic drug system officially released! Define five policy measures

[policies and regulations of chinapharma.com] on September 19, opinions on improving the national basic drug system (hereinafter referred to as "opinions") were officially released After 9 years, the opinions made adjustments at the top level of design, and made institutional arrangements in multiple links of essential drugs, which clarified the future development direction of national essential drug system and policies From the perspective of drug base selection criteria, safety, potency ratio and supporting consistency evaluation policy become the main melody of drug value judgment According to the regulation of base drug adjustment, the quantity and rhythm of base drug will be controlled by the central level, and infinite expansion of base drug will not be possible In addition, in principle, the adjustment period shall not exceed 3 years, and no drugs shall be added in all regions, and a small amount of ethnic drugs may be added in ethnic minority areas From the perspective of basic drug linkage medical insurance, the opinion insists on centralized procurement; specifies the proportion of use and improves the amount of use; the use of basic drugs will be linked to the payment method of medical insurance; the drugs in the directory of basic drugs will be included in medical insurance preferentially Specifically, the opinion mainly includes the selection, production, circulation, use, payment, monitoring and other links of essential drugs, and defines the policy measures of these links , dynamically adjust and optimize the directory Regular evaluation and dynamic adjustment of the list of essential drugs should be carried out to highlight the clinical value of drugs, attach equal importance to both Chinese and Western drugs, meet the main clinical needs of common diseases, chronic diseases, emergency rescue, and take into account the needs of children and other special groups and public health prevention and treatment "For the newly approved and listed drugs with significantly improved curative effect and reasonable price compared with the listed drugs, the transfer in procedure can be started in time; for the drugs with key transfer out and delisting, with more serious adverse reactions, which are not suitable to be used as basic drugs after evaluation, and the drugs with better risk-benefit ratio or cost-benefit ratio can be replaced." Second, we should ensure production and supply Adhere to the direction of centralized procurement and implement classified procurement of drugs We will do a good job in linking up the use of drugs by higher and lower level medical institutions, promote the centralized procurement of public medical institutions within the city (county) and promote the reduction of drug prices For the essential drugs that are easy to be in short supply, measures such as determining reasonable purchase price through market matching, fixed-point production, unified distribution or incorporation into reserves shall be taken to ensure the supply Third, full deployment gives priority to use "Medical institutions give priority to purchase and doctors give priority to use." Adhere to the leading position of basic drugs and make clear the proportion of basic drugs used in public medical institutions To carry out clinical use monitoring and comprehensive clinical evaluation of drugs We will deepen the reform of payment methods for medical insurance, establish payment standards for medical insurance, and guide rational diagnosis and treatment and rational use of drugs Fourth, reduce the burden of drug costs on the masses Priority should be given to the inclusion of essential drugs in the scope of the medical insurance catalogue according to the procedures, and the actual level of security should be gradually improved Encourage local governments to explore effective ways to reduce patients' burden and reduce patients' drug expenses to a large extent "Local governments are encouraged to organically integrate the basic drug system with hierarchical diagnosis and treatment, family doctors' contracted services, and chronic disease health management In the management of chronic diseases such as hypertension, diabetes, and severe mental disorders, basic drugs are given priority under the premise of ensuring the efficacy." Fifth, improve the quality and safety level We will carry out sampling inspection for all kinds of essential drugs, strengthen supervision and inspection of the production links of essential drugs, and strengthen quality and safety supervision For the drug varieties that pass the consistency evaluation, they shall be included in the basic drug catalog first according to the procedures; and the basic drug varieties that fail to pass the consistency evaluation shall be transferred out of the catalog gradually According to the analysis of the industry, it can be seen from the opinion that the competition in the market of public medical institutions will be the high-quality competition between safety and cost-effective drugs, while drugs without safety and cost-effective ratio will be difficult to enter the stage.